摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-1-methoxyphenanthridin-6(5H)-one | 1307740-63-1

中文名称
——
中文别名
——
英文名称
5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-1-methoxyphenanthridin-6(5H)-one
英文别名
5-Butyl-1-methoxy-2-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenanthridin-6-one;5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-1-methoxyphenanthridin-6-one
5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-1-methoxyphenanthridin-6(5H)-one化学式
CAS
1307740-63-1
化学式
C21H19F6NO3
mdl
——
分子量
447.377
InChiKey
ZDGVFRADHMKOMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    31
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    49.8
  • 氢给体数:
    1
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    2-(4-butylamino-2-methoxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol 在 palladium 10% on activated carbon 、 氢气 、 palladium diacetate 、 sodium hydride 、 potassium carbonatecaesium carbonate三乙胺 、 tricyclohexylphosphine tetrafluoroborate 作用下, 以 乙醇二氯甲烷2,4-滴二甲胺盐N,N-二甲基甲酰胺 为溶剂, 反应 14.5h, 生成 5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-1-methoxyphenanthridin-6(5H)-one
    参考文献:
    名称:
    Fused heterocyclic amido compounds as anti-hepatitis C virus agents
    摘要:
    We identified a fused heteroaromatic amido structure based on the phenanthridine skeleton as a superior scaffold for candidate drugs with potent anti-HCV activity. Among the compounds synthesized, a phenanthridine analogue with a 1,3-dioxolyl group (24) possessed the most potent anti-HCV activity (EC50 value: 50 nM), with acceptable cytotoxicity. The structural development and structure-activity relationships of these compounds are described. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.03.002
点击查看最新优质反应信息

文献信息

  • THERAPEUTIC AGENT FOR HEPATITIS C
    申请人:Kagoshima University
    公开号:EP2532652A1
    公开(公告)日:2012-12-12
    This invention provides a therapeutic agent for hepatitis C comprising, as an active ingredient, a compound having anti-HCV activity useful in treatment of hepatitis C. The therapeutic agent for hepatitis C comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    本发明提供了一种丙型肝炎治疗剂,其活性成分包括一种具有治疗丙型肝炎的抗-HCV 活性的化合物。
  • Fused heterocyclic amido compounds as anti-hepatitis C virus agents
    作者:Hiroshi Aoyama、Kazuyuki Sugita、Masahiko Nakamura、Atsushi Aoyama、Mohammed T.A. Salim、Mika Okamoto、Masanori Baba、Yuichi Hashimoto
    DOI:10.1016/j.bmc.2011.03.002
    日期:2011.4
    We identified a fused heteroaromatic amido structure based on the phenanthridine skeleton as a superior scaffold for candidate drugs with potent anti-HCV activity. Among the compounds synthesized, a phenanthridine analogue with a 1,3-dioxolyl group (24) possessed the most potent anti-HCV activity (EC50 value: 50 nM), with acceptable cytotoxicity. The structural development and structure-activity relationships of these compounds are described. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多